GL Pharm Tech

204840 · KOSDAQ · ₩204840 · 지엘팜텍

₩3,575▼ ₩5 (0.14%)End-of-day · Oct 28, 2026 · End-of-day prices.
Trade
Alert me

Filings

  • Amended: Major sales or supply contract[기재정정]단일판매ㆍ공급계약체결Sep 21, 2026Open on DART
  • Major management matter relevant to investors투자판단관련주요경영사항(임상시험계획승인신청등결정) (W2505 경구제 제 3상 임상시험계획(IND) 승인)Aug 21, 2026Open on DART
  • Half-year report (Jun 2026)반기보고서 (2026.06)Aug 13, 2026Open on DART
  • Trading halt주권매매거래정지해제 (액면병합 주권 변경상장)Aug 10, 2026Open on DART
  • 5%+ holding report주식등의대량보유상황보고서(일반)Aug 6, 2026Open on DART
  • Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Aug 6, 2026Open on DART
  • Merger Completion Report (Merger)합병등종료보고서(합병)Jul 31, 2026Open on DART
  • 5%+ holding report주식등의대량보유상황보고서(일반)Jul 29, 2026Open on DART
  • Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Jul 29, 2026Open on DART
  • Trading halt주권매매거래정지 (주식의 병합, 분할 등 전자등록 변경, 말소)Jul 14, 2026Open on DART
  • Results of Extraordinary Shareholders' Meeting임시주주총회결과Jul 6, 2026Open on DART
  • Other management matters기타경영사항(자율공시) (소규모합병 승인 이사회 결의 결과 보고)Jun 29, 2026Open on DART
  • Reference Document for Proxy Solicitation of Voting Rights의결권대리행사권유참고서류Jun 19, 2026Open on DART
  • Notice of shareholders' meeting주주총회소집공고Jun 19, 2026Open on DART
  • Amended attachment: Merger decision[첨부정정]주요사항보고서(회사합병결정)Jun 1, 2026Open on DART
  • Determination of Shareholder Register Closure Period or Record Date주주명부폐쇄기간또는기준일설정May 28, 2026Open on DART
  • Amended attachment: Merger decision[첨부정정]주요사항보고서(회사합병결정)May 28, 2026Open on DART
  • Merger decision주요사항보고서(회사합병결정)May 28, 2026Open on DART
  • Determination of Shareholder Register Closure Period or Record Date주주명부폐쇄기간또는기준일설정May 19, 2026Open on DART
  • Shareholders' meeting called주주총회소집결의 (임시주주총회)May 19, 2026Open on DART
  • Share Consolidation Decision주식병합결정May 19, 2026Open on DART
  • Quarterly report (Mar 2026)분기보고서 (2026.03)May 13, 2026Open on DART
  • Annual general meeting results정기주주총회결과Mar 26, 2026Open on DART
  • Audit report submitted감사보고서제출Mar 18, 2026Open on DART
  • Annual report (Dec 2025)사업보고서 (2025.12)Mar 18, 2026Open on DART
  • Shareholders' meeting called주주총회소집결의Mar 11, 2026Open on DART
  • Reference Document for Proxy Solicitation of Voting Rights의결권대리행사권유참고서류Mar 11, 2026Open on DART
  • Notice of shareholders' meeting주주총회소집공고Mar 11, 2026Open on DART
  • Change in Revenue or Profit/Loss Structure of 30% or More (15% or More for Large Companies)매출액또는손익구조30%(대규모법인은15%)이상변동Feb 9, 2026Open on DART
  • Quarterly report (Sep 2025)분기보고서 (2025.09)Nov 10, 2025Open on DART
  • Not Designated as Unfaithful Disclosure Company (Designation Deferred)불성실공시법인미지정 (지정유예)Sep 8, 2025Open on DART
  • Notice of Designation as Unfaithful Disclosure Company (Reversal of Disclosure)불성실공시법인지정예고 (공시번복)Aug 25, 2025Open on DART
  • Merger decision기타주요경영사항 (회사 합병결정 철회)Aug 14, 2025Open on DART
  • Half-year report (Jun 2025)반기보고서 (2025.06)Aug 14, 2025Open on DART
  • Amended: Merger decision[기재정정]주요사항보고서(회사합병결정)Aug 14, 2025Open on DART
  • Determination of Shareholder Register Closure Period or Record Date주주명부폐쇄기간또는기준일설정Jul 3, 2025Open on DART
  • Added attachment: Merger decision[첨부추가]주요사항보고서(회사합병결정)Jul 3, 2025Open on DART
  • Quarterly report (Mar 2025)분기보고서 (2025.03)May 12, 2025Open on DART
  • Annual general meeting results정기주주총회결과Mar 26, 2025Open on DART
  • Notice on Grant of Stock Purchase Options주식매수선택권부여에관한신고Mar 26, 2025Open on DART
  • Report on Appointment, Dismissal, or Mid-Term Resignation of Independent Directors독립이사의선임ㆍ해임또는중도퇴임에관한신고Mar 26, 2025Open on DART
  • Audit report submitted감사보고서제출Mar 18, 2025Open on DART
  • Annual report (Dec 2024)사업보고서 (2024.12)Mar 18, 2025Open on DART
  • Shareholders' meeting called주주총회소집결의Mar 11, 2025Open on DART
  • [Amended] Reference Document for Proxy Solicitation of Voting Rights[기재정정]의결권대리행사권유참고서류Mar 11, 2025Open on DART
  • Reference Document for Proxy Solicitation of Voting Rights의결권대리행사권유참고서류Mar 11, 2025Open on DART
  • Notice of shareholders' meeting주주총회소집공고Mar 11, 2025Open on DART
  • Change in Revenue or Profit/Loss Structure of 30% or More (15% or More for Large Companies)매출액또는손익구조30%(대규모법인은15%)이상변동Feb 11, 2025Open on DART
  • Determination of Shareholder Register Closure Period or Record Date주주명부폐쇄기간또는기준일설정Dec 13, 2024Open on DART
  • Quarterly report (Sep 2024)분기보고서 (2024.09)Nov 14, 2024Open on DART

Titles in Korean until English translations are added.

Also known as: GL Pharm Tech / 지엘팜텍 / 204840 / KRX:204840

Source: KRX statistical information